NEDD4L and pancreatic neoplasm: Of note, it was shown that NEDD4L, through inhibiting autophagy, impaired mitochondrial metabolism by disrupting the cellular oxygen consumption rate (OCR), the mitochondrial membrane potential (MMP), and mitochondrial morphology to ultimately suppress pancreatic tumor growth.